Lower-dose fractionated stereotactic radiotherapy results in better hearing preservation

Researchers at Thomas Jefferson University have found that a lower dose of fractionated stereotactic radiotherapy for acoustic neuromas results in better hearing preservation and has the same tumor local control rate as a higher dose of therapy. The study appeared online in the International Journal of Radiation Oncology*Biology*Physics.

Read the whole article on Physorg

More from Physorg